PALLIATIVE ANTINEOPLASTIC THERAPY FOR THE TREATMENT OF MAXILLOFACIAL OSTEOSARCOMA IN A DOG
DOI:
https://doi.org/10.51891/rease.v9i6.10344Keywords:
Diagnosis. Neoplasm. Veterinary oncology. Chemotherapy.Abstract
Maxillofacial osteosarcoma is a rare malignant bone neoplasm that primarily affects flat bones. It is associated with genetic factors, with a higher predisposition in large or giant breed dogs. Diagnosis is based on radiographic findings, and confirmation is obtained through histopathological examination. This case report describes a 6-year-old female French Bulldog with maxillofacial osteosarcoma. The patient presented to Aukmia Veterinary Hospital with a localized swelling on the right side of the face. The diagnosis was confirmed through histopathological examination, which revealed the presence of atypical cellular proliferation of slightly elongated star-shaped cells. The patient underwent antineoplastic therapy with carboplatin combined with firocoxib, with three sessions performed. However, after the third session, the patient's clinical condition worsened, leading to euthanasia.
Downloads
Published
How to Cite
Issue
Section
License
Atribuição CC BY